#United States #New York #Class Action #Levi & Korsinsky #Inc. #RxSight

Investors of RxSight, Inc. Invited to Participate in Class Action Lawsuit

Introduction
RxSight, Inc., publicly traded under the ticker RXST, is currently facing legal challenges that could affect its investors significantly. Levi & Korsinsky, LLP, a well-known law firm specializing in class action suits, is calling upon affected shareholders to join a class action lawsuit in a bid to recover losses attributable to alleged securities fraud.

Background of the Case
According to the firm, the class action lawsuit pertains to specific periods between November 7, 2024, and July 8, 2025. During this time, it is alleged that the company and its representatives misled investors by making false statements concerning the company's operational health. The lawsuit asserts that RxSight was grappling with adoption challenges and structural issues, leading to a noticeable decline in product sales and usage.

Significantly, the firm claims that the defendants falsely overstated the demand for RxSight's offerings. As a result of these actions, the failure to meet financial forecasts for the fiscal year 2025 was inevitable. This disparity between the company’s claims and the actual circumstances has purportedly misled investors, resulting in financial losses.

Details for Interested Investors
If you have been impacted by these alleged actions, you are encouraged to take action promptly. The deadline for filing a request as a lead plaintiff in this class action lawsuit is September 22, 2025, which means affected investors still have a limited window to participate. However, it is crucial to note that becoming a lead plaintiff is not mandatory to share in any potential recovery; all class members may be eligible for compensation at no upfront cost.

Investors can contact Joseph E. Levi at Levi & Korsinsky directly at (212) 363-7500 or via email for inquiries related to this case. Additional information, including details about the lawsuit and how to get involved, can be found here.

Why Choose Levi & Korsinsky?
Over the last two decades, Levi & Korsinsky has built a reputation for successfully securing substantial settlements for aggrieved shareholders. Their expertise in complex securities litigation positions them as a trusted representative for investors facing challenges such as these. With a dedicated team of over 70 professionals, the firm is equipped to provide comprehensive legal support throughout the lawsuit process.

Furthermore, for the seventh consecutive year, they have been recognized among the top 50 securities litigation firms in the United States, according to ISS Securities Class Action Services. This accolade reflects their significant track record in advocating for investor rights.

Conclusion
Investors in RxSight, Inc. are advised to stay informed and consider participating in this critical class action suit. The firm’s efforts to expose alleged securities fraud could potentially offer a pathway to recovering lost investments. For further details on how to engage with the lawsuit, get in touch with Levi & Korsinsky while ensuring you do so before the nearing deadline.

Contact Information
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com